|
Deferoxamine MesylateDrug - Deferoxamine Mesylate The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Deferoxamine Mesylate
Strength -
2GM/VIAL
Applicant -
HOSPIRA
New Drug Application (NDA) Number -
076019
Product Number -
002
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Mar 17, 2004
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Hospira Inc
Deferoxamine Mesylate
Cerubidine Eq 20mg Base/vial Injectable; Injection
Cerubidine Eq 20mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 5mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 20mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 5mg Base/ml Injectable; Injection Daunorubicin Hcl Eq 20mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 50mg Base/vial Injectable; Injection Daunorubicin Hcl Eq 5mg Base/ml Injectable; Injection Syncurine 1mg/ml Injectable; Injection Deferoxamine Mesylate 2gm/vial Injectable; Injection NewDrugInformation |